Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2014
11/06/2014US20140331343 Antibodies, variable domains & chains tailored for human use
11/06/2014US20140329996 Tissue specific expression of antibodies in chickens
11/06/2014US20140329911 Predictive marker of dnmt1 inhibitor therapeutic efficacy and methods of using the marker
11/06/2014US20140329711 Histidine Engineered Light Chain Antibodies and Genetically Modified Non-Human Animals for Generating the Same
11/06/2014US20140329320 Nanoantibodies, Binding Chlamydia Trachomatis Antigen, Method for Inhibition of Infection Induced by Chlamydia Trachomatis
11/06/2014US20140329312 Method for producing human monoclonal immunoglobulin g antibodies
11/06/2014US20140329279 Compositions for cell culture and methods of using the same
11/06/2014US20140329278 Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
11/06/2014US20140329276 Methods for increasing n-glycan occupancy and reducing production of hybrid n-glycans in pichia pastoris strains lacking alg3 expression
11/06/2014US20140329253 Monoclonal Antibody For The Detection of SNAP/CLIP Tag
11/06/2014US20140328940 Modulation of axon degeneration
11/06/2014US20140328864 Methods and pharmaceutical compositions for reducing airway hyperresponse
11/06/2014US20140328862 Human immunodeficiency virus neutralizing antibodies and methods of use thereof
11/06/2014US20140328861 Combination of CRTH2 Antagonist and a Proton Pump Inhibitor for the Treatment of Eosinophilic Esophagitis
11/06/2014US20140328860 Methods for stimulating hematopoietic recovery by inhibiting tgf beta signaling
11/06/2014US20140328859 Antibodies and methods for wnt pathway-related diseases
11/06/2014US20140328858 Lin28-mediated control of let-7 biogenesis
11/06/2014US20140328857 Novel B7-H3L Cell Surface Antigen and Antibodies That Bind Thereto
11/06/2014US20140328856 Treatment of alzheimer's disease subpopulations with pooled immunoglobulin g
11/06/2014US20140328855 Method of treating ankylosing spondylitis
11/06/2014US20140328853 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for prevention or reduction of organ dysfunction or organ failure in a patient having a chronic or acute disease or acute condition
11/06/2014US20140328852 Immunogenic gluten peptides and uses thereof
11/06/2014US20140328851 Cholesterol Ester Transfer Protein (CETP) Inhibitor Polypeptide Antibodies for Prophylactic and Therapeutic Anti-Atherosclerosis Treatments
11/06/2014US20140328850 Apelin antigen-binding proteins and uses thereof
11/06/2014US20140328849 Anti-crth2 antibodies and methods of use
11/06/2014US20140328848 Method for Treating Metabolic Disorders
11/06/2014US20140328847 Mitigation of disease by inhibition of galectin-12
11/06/2014US20140328846 Anti-properdin antibodies
11/06/2014US20140328845 Methods for increasing thermogenic adipocytes
11/06/2014US20140328844 Methods of use for taci-immunoglobulin fusion proteins
11/06/2014US20140328841 Anti-ceacam1 recombinant antibodies for cancer therapy
11/06/2014US20140328840 Marker and target for responsiveness and resistance to cancer agents
11/06/2014US20140328839 Methods For Reducing The Frequency And Severity Of Acute Exacerbations Of Asthma
11/06/2014US20140328838 Caninised antibodies and method for production of same
11/06/2014US20140328836 HER2/neu-Specific Antibodies and Methods of Using Same
11/06/2014US20140328835 Methods for treating retinopathy with extended therapeutic effect
11/06/2014US20140328833 Methods for treating cancer using anti-pd-1 antibodies
11/06/2014US20140328831 Single domain tdf-related compounds and analogs thereof
11/06/2014US20140328830 Anti-integrin beta-1 antibody compositions and methods of use thereof
11/06/2014US20140328829 Agr2 blocking antibody and use thereof
11/06/2014US20140328824 Diagnostic and Therapeutic Methods and Their Application in Amyotrophic Lateral Sclerosis (ALS)
11/06/2014US20140328812 Chimeric receptors with 4-1bb stimulatory signaling domain
11/06/2014US20140328797 Human rhinovirus (hrv) antibodies
11/06/2014US20140328758 Use of fsh receptor ligands for diagnosis and therapy of cancer
11/06/2014US20140328753 Antibodies for Molecular Imaging of Vulnerable Plaques in Atherosclerosis
11/06/2014US20140328751 Antibodies that bind ov064 and methods of use therefor
11/06/2014US20140328750 Antibodies Reactive with B7-H3 and Uses Thereof
11/04/2014US8877904 Chromatography purification of antibodies
11/04/2014US8877901 Camptothecin-binding moiety conjugates
11/04/2014US8877900 AX132 PCSK9 antagonists
11/04/2014US8877899 Anti-CD38 antibody and lenalidomide or bortezomib for the treatment of multipe myeloma and NHL
11/04/2014US8877898 Fluorescent fusion polypeptides and methods of use
11/04/2014US8877897 Compositions and methods for the diagnosis and treatment of tumor
11/04/2014US8877777 Process for purifying cyclolipopeptide compounds or the salts thereof
11/04/2014US8877715 Cytotoxic conjugates having neuropeptide Y receptor binding compound
11/04/2014US8877706 Maytansinoid derivatives
11/04/2014US8877686 Surface display of recombinant proteins in lower eukaryotes
11/04/2014US8877491 Polynucleotides encoding humanized anti-NGF antibodies
11/04/2014US8877443 Method and kit for evaluation of predisposition to development of obesity, anti-obesity agent and method for screening thereof, non-human animal, adipose tissue, adipocyte, method for production of transgenic mouse, antigen, and antibody
11/04/2014US8877202 Pro-drug form (P2PDOX) of the highly potent 2-pyrrolinodoxorubicin conjugated to antibodies for targeted therapy of cancer
11/04/2014US8877201 Bordetella outer-membrane protein antigens and methods of making and using the same
11/04/2014US8877200 HA binding agents
11/04/2014US8877199 B cell surface reactive antibodies
11/04/2014US8877198 Methods of reducing phosphate absorption
11/04/2014US8877197 Anti-complement C1s
11/04/2014US8877194 TNF-α binding proteins
11/04/2014US8877191 Antibodies to the PcrV antigen of Pseudomonas aeruginosa
11/04/2014US8877190 Aβ conformer selective anti-Aβ globulomer monoclonal antibodies
11/04/2014US8877189 Binding members for interleukin-4 receptor alpha (IL-4Rα) - 173
11/04/2014US8877188 Detection and treatment of non-dermal fibrosis
11/04/2014US8877187 Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases
11/04/2014US8877186 Polypeptides, antibody variable domains and antagonists
10/2014
10/30/2014US20140323698 Protein purification using bis-tris buffer
10/30/2014US20140323697 Media for affinity chromatography
10/30/2014US20140323696 Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating Methods
10/30/2014US20140323695 Protein purification method
10/30/2014US20140323693 Antibodies To Non-Functional P2X7 Receptor
10/30/2014US20140322757 Antibodies that bind colony stimulating factor 1 receptor (csf1r)
10/30/2014US20140322756 Method for making multispecific antibodies having heteromultimeric and common components
10/30/2014US20140322731 AMYLOID BETA-DERIVED DIFFUSIBLE LIGANDS (ADDLs), ADDL-BINDING MOLECULES, AND USES THEREOF
10/30/2014US20140322730 Botulinum Neurotoxin E Receptors and Uses Thereof
10/30/2014US20140322726 Monoclonal antibody specifically recognizing asparagine synthetase
10/30/2014US20140322306 Medical Use
10/30/2014US20140322275 TREATMENT OF CANCER USING HUMANIZED ANTI-EGFRvIII CHIMERIC ANTIGEN RECEPTOR
10/30/2014US20140322248 Dual Specific Immunotoxin for Brain Tumor Therapy
10/30/2014US20140322246 IGE ANTI-HMW-MAA Antibody
10/30/2014US20140322244 Mic-binding antibodies and methods of use thereof
10/30/2014US20140322242 Materials and methods for the prevention and treatment of cancer
10/30/2014US20140322241 Methods of regulating angiogenesis and compositions capable of same
10/30/2014US20140322240 Malaria vaccine
10/30/2014US20140322239 Anti-il-6 receptor antibodies and methods of use
10/30/2014US20140322238 IL-17RA-IL-17RB Antagonists and Uses Thereof
10/30/2014US20140322236 Anti-human adora2a antibodies
10/30/2014US20140322235 Anti-cd277 antibodies and uses thereof
10/30/2014US20140322234 Analysis and Targeting of ROR2 in Cancer
10/30/2014US20140322233 Anti-gcc antibody molecules and related compositions and methods
10/30/2014US20140322232 Methods of administering anti-tnfalpha antibodies
10/30/2014US20140322231 Osteoprotegerin in neuroprotection
10/30/2014US20140322228 Formulation of human antibodies for treating tnf-alpha associated disorders
10/30/2014US20140322225 Anti-Adrenomedullin (ADM) antibody or anti-ADM antibody fragment or anti-ADM non-Ig scaffold for use in therapy of an acute disease or acute condition of a patient for stabilizing the circulation
1 ... 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 ... 1494